[1] For recent reviews, see: (a) Clive, D. L. J.; Yu, M.; Wang, J.; Yeh, V. S. C.; Kang, S. Chem. Rev. 2005, 105, 4483.(b) Galliford, C. V.; Scheidt, K. A. Angew. Chem. Int. Ed. 2007, 46, 8748.(c) Millemaggi, A.; Taylor, R. J. K. Eur. J. Org. Chem. 2010, 4527.(d) Yu, J.; Shi, F.; Gong, L.-Z. Acc. Chem. Res. 2011, 44, 1156.(e) Rios, R. Chem. Soc. Rev. 2012, 41, 1060.(f) Franz, A. K.; Hanhan, N. V.; Ball-Jones, N. R. ACS Catal. 2013, 3, 540.[2] For selected recent examples, see: (a) Yip, K.-T.; Zhu, N.-Y.; Yang, D. Org. Lett. 2009, 11, 1911.(b) Girgis, A. S. Eur. J. Med. Chem. 2009, 44, 91.(c) Sirasani, G.; Andrade, R. B. Org. Lett. 2009, 11, 2085.(d) Cheng, L.; Liu, L.; Jia, H.; Wang, D.; Chen, Y.-J. J. Org. Chem. 2009, 74, 4650.(e) Li, B.; Zhou, R.; He, G.; Guo, L.; Huang, W. Acta Chim. Sinica 2013, 71, 1396. (李博, 周锐, 何谷, 郭丽, 黄维, 化学学报, 2013, 71, 1396.) For chapters and selected reviews, see:(f) Indoles, Ed.: Sundberg, R. J., Academic Press, San Diego, CA, 1996.(g) Kleeman, A.; Engel, J.; Kutscher, B.; Reichert, D. Pharmaceutical Substances, 4th ed., Thieme, New York, 2001.(h) Dewick, P. M. Medicinal Natural Products: A Biosynthetic Approach, 2nd ed., Wiley, New York, 2002.(i) Fattorusso, E.; Scafati, O. T. Modern Alkaloids, WILEY-VCH, Weinheim, 2008.(j) Knölker, H. J.; Reddy, K. R. Chem. Rev. 2002, 102, 4303.(k) Cacchi, S.; Fabrizi, G. Chem. Rev. 2005, 105, 2873.[3] (a) Wang, Y.; Ding, K. Chin. J. Org. Chem. 2001, 21, 763. (王以, 丁奎岭, 有机化学, 2001, 21, 763. )(b) Zeni, G.; Larock, R. C. Chem. Rev. 2004, 104, 2285.(c) Sheng, Y.-F.; Zhang, A.-J.; Zheng, X.-J.; You, S.-L. Chin. J. Org. Chem. 2008, 28, 605. (盛益飞, 张安将, 郑晓建, 游书力, 有机化学, 2008, 28, 605.)(d) Bandini, M.; Eichholzer, A. Angew. Chem. Int. Ed. 2009, 48, 9608.[4] Selected recent examples for the asymmetric synthesis of tetrahydrocarbazoles, see: (a) Gioia, C.; Hauville, A.; Bernardi, L.; Fini, F.; Ricci, A. Angew. Chem. Int. Ed. 2008, 47, 9236.(b) Jones, S. B.; Simmons, B.; MacMillan, D. W. C. J. Am. Chem. Soc. 2009, 131, 13606.(c) Bandini, M.; Eichholzer, A.; Gualandi, A.; Quinto, T.; Savoia, D. ChemCatChem 2010, 2, 661.(d) Tan, B.; Hernández-Torres, G.; Barbas Ⅲ, C. F. J. Am. Chem. Soc. 2011, 133, 12354.(e) Müller, S.; Webber, M. J.; List, B. J. Am. Chem. Soc. 2011, 133, 18534.(f) Liu, Y.; Nappi, M.; Arceo, E.; Vera, S.; Melchiorre, P. J. Am. Chem. Soc. 2011, 133, 15212.(g) Cai, Q.; Zheng, C.; Zhang, J.-W.; You, S.-L. Angew. Chem. Int. Ed. 2011, 50, 8665.(h) Cai, Q.; You, S.-L. Org. Lett. 2012, 14, 3040.(i) Wu, Q.-F.; Zheng, C.; You, S.-L. Angew. Chem. Int. Ed. 2012, 51, 1680.(j) Liu, Y.; Nappi, M.; Escudero-Adán, E. C.; Melchiorre, P. Org. Lett. 2012, 14, 1310.(k) Xiao, Y.-C.; Zhou, Q.-Q.; Dong, L.; Liu, T.-Y.; Chen, Y.-C. Org. Lett. 2012, 14, 5940.(l) Bandini, M.; Bottoni, A.; Chiarucci, M.; Cera, G.; Miscione, G. P. J. Am. Chem. Soc. 2012, 134, 20690.[5] Murdock, K. C. J. Org. Chem. 1959, 24, 845.[6] (a) Khordorkovsky, V.; Mazor, R. A.; Ellern, A. Acta Crystallogr. 1996, C52, 2878.(b) Schwartz, H.; Mazor, R.; Khordorkovsky, V.; Shapiro, L.; Klug, J. T.; Kovalev, E.; Meshulum, G.; Berkovic, G.; Kotler, Z.; Efrima, S. J. Phys. Chem. 2001, 105, 5914.[7] Nishiyama, T.; Shiotsu, S.; Tsujita, H. Polym. Degrad. Stab. 2002, 76, 435.[8] (a) Nugiel, D.; Etzkorn, A.; Vidwans, A.; Benfield, P.; Bosclair, M.; Burton, C.; Cox, S.; Czerniak, M.; Doleniak, D.; Seitz, S. J. Med. Chem. 2001, 44, 1334.(b) Nugiel, D.; Vidwans, A.; Etzkorn, A.; Rossi, K.; Benfield, P.; Burton, C.; Cox, S.; Czerniak, M.; Doleniak, D.; Seitz, S. J. Med. Chem. 2002, 45, 5224.[9] For preparation of 2-arylidene-1,3-indanediones, please see: (a) Inayama, S.; Mamoto, K.; Shibata, T.; Hirose, T. J. Med. Chem. 1976, 19, 433.(b) Wu, D. Y.; Ren, Z. J.; Cao, W. G.; Tong, W. Q. Synth. Commun. 2005, 35, 3157.(c) Sarvesh, P. K.; Nizamuddin, K. Arch. Pharm. Chem. Life Sci. 2008, 341, 418.[10] For the asymmetric epoxidation, see: (a) Russo, A.; Lattanzi, A. Org. Biomol. Chem. 2010, 8, 2633. For the asymmetric cyclopropanation, see:(b) Russo, A.; Meninno, S.; Tedesco, C.; Lattanzi, A. Eur. J. Org. Chem. 2011, 5096.[11] Hua, F.-L.; Wei, Y.; Shi, M. Tetrahedron 2012, 68, 7911.[12] (a) Ramachary, D. B.; Anebouselvy, K.; Chowdari, N. S.; Barbas Ⅲ, C. F. J. Org. Chem. 2004, 69, 5838. For an asymmetric [2+2+2] annulation, see:(b) Kuan, H.-H.; Chien, C.-H.; Chen, K. Org. Lett. 2013, 15, 2880. For a non-asymmetric [4+2] cycloaddition, see:(c) Li, E.-Q.; Huang, Y.; Liang, L.; Xie, P.-Z. Org. Lett. 2013, 15, 3138.[13] (a) Lu, H.-H.; Liu, H.; Wu, W.; Wang, X.-F.; Lu, L.-Q.; Xiao, W.-J. Chem. Eur. J. 2009, 15, 2742.(b) Wang, X.-F.; Hua, Q.-L.; Cheng, Y.; An, X.-L.; Yang, Q.-Q.; Chen, J.-R.; Xiao, W.-J. Angew. Chem. Int. Ed. 2010, 49, 8379.(c) Wang, X.-F.; Cao, Y.-J.; Cheng, H.-G.; Chen, J.-R.; Xiao, W.-J. Org. Lett. 2010, 12, 1140.(d) Zhu, X.-Y.; An, X.-L.; Li, C.-F.; Zhang, F.-G.; Hua, Q.-L.; Chen, J.-R.; Xiao, W.-J. ChemCatChem 2011, 3, 679.(e) Cao, Y.-J.; Cheng, H.-G.; Lu, L.-Q.; Zhang, J.-J.; Cheng, Y.; Chen, J.-R.; Xiao, W.-J. Adv. Synth. Catal. 2011, 353, 617.(f) Tan, F.; Xiao, C.; Cheng, H.-G.; Wu, W.; Ding, K.-R.; Xiao, W.-J. Chem. Asian J. 2012, 7, 493.(g) Tan, F.; Cheng, H.-G.; Feng, B.; Zou, Y.-Q.; Duan, S.-W.; Chen, J.-R.; Xiao, W.-J. Eur. J. Org. Chem. 2013, 2071.(h) Cheng, H.-G.; Lu, L.-Q.; Wang, T.; Yang, Q.-Q.; Liu, X.-P.; Li, Y.; Deng, Q.-H.; Chen, J.-R.; Xiao, W.-J. Angew. Chem. Int. Ed. 2013, 52, 3250.(i) Tan, F.; Lu, L.-Q.; Yang, Q.-Q.; Guo, W.; Bian, Q.; Chen, J.-R.; Xiao, W.-J. Chem. Eur. J. 2014, 20, 3415.[14] Cheng, H.-G.; Lu, L.-Q.; Wang, T.; Chen, J.-R.; Xiao, W.-J. Chem. Commun. 2012, 48, 5596.[15]For selected reviews on the applications of chiral bis(oxazoline) ligands in asymmetric catalysis, see: (a) Johnson, J. S.; Evans, D. A. Acc. Chem. Res. 2000, 33, 325.(b) Desimoni, G.; Faita, G.; Jørgensen, K. A. Chem. Rev. 2006, 106, 3561.(c) Hargaden, G. C.; Guiry, P. J. Chem. Rev. 2009, 109, 2505.(d) Desimoni, G.; Faita, G.; Jørgensen, K. A. Chem. Rev. 2011, 111, PR284. |